This study has two objectives. Firstly, it explores how do R&D narratives differ in various clusters of biopharmaceutical companies in terms of discussion context and text readability. Secondly, it examines whether the way how biopharmaceutical companies depict their business within R&D context is dependent on R&D expenses or R&D intensity levels. The paper contributes to the literature in applying qualitative and quantitative methods.